Max Planck Society - eDoc Server

Characterization of p53 activator compounds which inhibit a survival factor kinase as well
Authors: Belle, R.; Baska, F.; Orfi, Z.; Szantai-Kis, C.; Sipos, A.; Breza, N.; Borbely, G.; Penzes, K.; Orfi, L.; Keri, G.
Date of Publication (YYYY-MM-DD): 2012-09
Title of Journal: FEBS Journal
Volume: 279
Issue / Number: Suppl. 1 Sp. Iss.
Start Page: 179
End Page: 179
Document Type: Article
ID: 625646.0

Signal transduction therapy with rationally designed kinase inhibitors
Authors: Keri, G.; Orfi, L.; Eros, D.; Hegymegi-Barakonyi, B.; Szantai-Kis, C.; Horvath, Z.; Waczek, F.; Marosfalvi, J.; Szabadkai, I.; Pato, J.; Greff, Z.; Hafenbradl, D.; Daub, H.; Muller, G.; Klebl, B.; Ullrich, A.
Date of Publication (YYYY-MM-DD): 2006-01
Title of Journal: Current Signal Transduction Therapy
Volume: 1
Issue / Number: 1
Start Page: 67
End Page: 95
Document Type: Article
ID: 318840.0

Prediction oriented QSAR modelling of EGFR inhibition
Authors: Szantai-Kis, C.; Kovesdi, I.; Eros, D.; Banhegyi, P.; Ullrich, A.; Keri, G.; Orfi, L.
Date of Publication (YYYY-MM-DD): 2006
Title of Journal: Current Medicinal Chemistry
Volume: 13
Issue / Number: 3
Start Page: 277
End Page: 287
Document Type: Article
ID: 288905.0

Drug discovery in the kinase inhibitory field using the nested chemical libraryTM technology
Authors: Kéri, G.; Székelyhidi, Z.; Bánhegyi, Z.; Varga, Z.; Hegymegi-Barakonyi, B.; Szántai-Kis, C.; Hafenbradl, D.; Klebl, B.; Müller, G.; Ullrich, A.; Erös, D.; Horváth, Z.; Greff, Z.; Marosfalvi, J.; Pató, J.; Szabadkai, I.; Szilágyi, I.; Szegedi, Z.; Varga, I.; Wáczek, F.; Örfi, L.
Date of Publication (YYYY-MM-DD): 2005
Title of Journal: Assay and Drug Development Technologies
Volume: Assay Drug Dev. Technol.
Start Page: 543
End Page: 552
Document Type: Article
ID: 275638.0